Literature DB >> 26073576

Interleukin-6 controls uterine Th9 cells and CD8(+) T regulatory cells to accelerate parturition in mice.

Nardhy Gomez-Lopez1,2,3,4, David M Olson5, Sarah A Robertson1.   

Abstract

Interleukin-6 (IL6) is a determinant of the timing of parturition and birth in mice. We previously demonstrated that genetic IL6 deficiency delays parturition by ~24 h, and this is restored by administration of exogenous IL6. In this study, we have investigated whether IL6 influences the number or phenotypes of T cells or other leukocytes in uterine decidual tissue at the maternal-fetal interface. In late gestation, decidual leukocytes in Il6 null mutant (Il6(-/-)) mice exhibit an altered profile, characterized by reduced numbers of cells expressing the monocyte/macrophage marker F4/80 or the T-cell marker CD4, increased cells expressing the natural killer (NK) cell marker CD49b or the dendritic cell marker CD11c, but no change in cells expressing the neutrophil marker Ly6G. These changes are specific to late pregnancy, as similar differences in decidual leukocytes were not evident in mid-gestation Il6(-/-) mice. The IL6-regulated changes in decidual NK and dendritic cells appear secondary to local recruitment, as no comparable changes occurred in peripheral blood of Il6(-/-) mice. When exogenous IL6 was administered to restore normal timing of parturition, a partial reversal of the altered leukocyte profile was observed, with a 10% increase in the proportion of decidual CD4(+) T cells, a notable 60% increase in CD8(+) T cells including CD8(+)CD25(+)Foxp3(+) regulatory T cells and a 60% reduction in CD4(+)IL9(+) Th9 cells. Together these findings suggest that IL6-controlled accumulation of decidual CD4(+) T cells and CD8(+) regulatory T cells, with an associated decline in decidual Th9 cells, is instrumental for progressing parturition in mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26073576     DOI: 10.1038/icb.2015.63

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  63 in total

1.  Increased T-cell activation in decidua parietalis compared to decidua basalis in uncomplicated human term pregnancy.

Authors:  A Sindram-Trujillo; S Scherjon; H Kanhai; D Roelen; F Claas
Journal:  Am J Reprod Immunol       Date:  2003-05       Impact factor: 3.886

2.  IL-1 serves as a secondary signal for IL-9 expression.

Authors:  E Schmitt; H U Beuscher; C Huels; P Monteyne; R van Brandwijk; J van Snick; E Ruede
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

3.  Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term.

Authors:  Anne Young; Andrew J Thomson; MarieAnne Ledingham; Fiona Jordan; Ian A Greer; Jane E Norman
Journal:  Biol Reprod       Date:  2002-02       Impact factor: 4.285

4.  Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface.

Authors:  Marcia Arenas-Hernandez; Elly N Sanchez-Rodriguez; Tara N Mial; Sarah A Robertson; Nardhy Gomez-Lopez
Journal:  J Vis Exp       Date:  2015-05-21       Impact factor: 1.355

Review 5.  Preterm labor: one syndrome, many causes.

Authors:  Roberto Romero; Sudhansu K Dey; Susan J Fisher
Journal:  Science       Date:  2014-08-14       Impact factor: 47.728

6.  Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process.

Authors:  A J Thomson; J F Telfer; A Young; S Campbell; C J Stewart; I T Cameron; I A Greer; J E Norman
Journal:  Hum Reprod       Date:  1999-01       Impact factor: 6.918

7.  Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection.

Authors:  U Santhanam; C Avila; R Romero; H Viguet; N Ida; S Sakurai; P B Sehgal
Journal:  Cytokine       Date:  1991-03       Impact factor: 3.861

8.  Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term.

Authors:  Inass Osman; Anne Young; Marie Anne Ledingham; Andrew J Thomson; Fiona Jordan; Ian A Greer; Jane E Norman
Journal:  Mol Hum Reprod       Date:  2003-01       Impact factor: 4.025

9.  Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration.

Authors:  Congcong Zhang; Yulin Li; Yina Wu; Luya Wang; Xiaonan Wang; Jie Du
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

10.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  27 in total

1.  Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Piya Chaemsaithong; Roberto Romero; Nikolina Docheva; Noppadol Chaiyasit; Gaurav Bhatti; Percy Pacora; Sonia S Hassan; Lami Yeo; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

2.  Maternal and fetal intrauterine tissue crosstalk promotes proinflammatory amplification and uterine transition†.

Authors:  Kelycia B Leimert; Angela Messer; Theora Gray; Xin Fang; Sylvain Chemtob; David M Olson
Journal:  Biol Reprod       Date:  2019-03-01       Impact factor: 4.285

3.  Differential senescence in feto-maternal tissues during mouse pregnancy.

Authors:  Elizabeth A Bonney; Kendall Krebs; George Saade; Talar Kechichian; Jayshil Trivedi; Yin Huaizhi; Ramkumar Menon
Journal:  Placenta       Date:  2016-04-24       Impact factor: 3.481

4.  The effects of advanced maternal age on T-cell subsets at the maternal-fetal interface prior to term labor and in the offspring: a mouse study.

Authors:  D Levenson; R Romero; V Garcia-Flores; D Miller; Y Xu; A Sahi; S S Hassan; N Gomez-Lopez
Journal:  Clin Exp Immunol       Date:  2020-05-07       Impact factor: 4.330

5.  Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection.

Authors:  Eli Maymon; Roberto Romero; Gaurav Bhatti; Piya Chaemsaithong; Nardhy Gomez-Lopez; Bogdan Panaitescu; Noppadol Chaiyasit; Percy Pacora; Zhong Dong; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2018-02-23       Impact factor: 1.901

6.  In vivo activation of invariant natural killer T cells induces systemic and local alterations in T-cell subsets prior to preterm birth.

Authors:  N Gomez-Lopez; R Romero; M Arenas-Hernandez; G Schwenkel; D St Louis; S S Hassan; T N Mial
Journal:  Clin Exp Immunol       Date:  2017-05-10       Impact factor: 4.330

Review 7.  Immune Regulation in Pregnancy: A Matter of Perspective?

Authors:  Elizabeth A Bonney
Journal:  Obstet Gynecol Clin North Am       Date:  2016-10-14       Impact factor: 2.844

Review 8.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

9.  Stretch, scratch, and stress: Suppressors and supporters of senescence in human fetal membranes.

Authors:  Lauren S Richardson; Enkhtuya Radnaa; Rheanna Urrabaz-Garza; Narmada Lavu; Ramkumar Menon
Journal:  Placenta       Date:  2020-07-25       Impact factor: 3.481

10.  Invariant NKT Cell Activation Induces Late Preterm Birth That Is Attenuated by Rosiglitazone.

Authors:  Derek St Louis; Roberto Romero; Olesya Plazyo; Marcia Arenas-Hernandez; Bogdan Panaitescu; Yi Xu; Tatjana Milovic; Zhonghui Xu; Gaurav Bhatti; Qing-Sheng Mi; Sascha Drewlo; Adi L Tarca; Sonia S Hassan; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2016-01-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.